Bio Protocol vs VeThor Token — how do they compare? Bio Protocol trades at Rp442.42 (market cap Rp1T, Rp162,69M 24h volume), while VeThor Token trades at Rp5.64 (market cap Rp579,51M, Rp16,37M 24h volume). The key difference: Bio Protocol is far larger — about 1725.6× VeThor Token's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while VeThor Token's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and VeThor Token for 42 Days on average.
| BIO | VTHO | |
|---|---|---|
Market Cap | Rp1T | Rp579,51M |
Volume (24h) | Rp162,69M | Rp16,37M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 102,2B VTHO |
Typical Hold Time | 18 Days | 42 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
VeThor Token (VTHO) is trading at Rp5.7611 with a market cap of Rp589.58M, showing a bearish technical signal driven by moving averages. The RSI readings are neutral, but ADX indicates a strong downtrend. Support and resistance levels are consolidated at Rp6. No major protocol updates or ecosystem news were identified recently.
Overall outlook is cautious due to bearish momentum and low liquidity. Key opportunities include potential rebounds from oversold conditions, while major risks involve high volatility and limited market depth. Investors should monitor on-chain activity for signs of network growth.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →VeThor Token is one of the two tokens employed by the VeChainThor public blockchain. VeChain was initially launched in 2015, but it went through a heavy rebranding process in 2018. While VeChain Token (VET) is the native token for the platform, VeThor Token (VTHO) plays an essential role in the overall functionality of the blockchain.
Read more on VTHO →